UBS AM’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$123M Buy
207,309
+3,958
+2% +$1.97M 0.03% 471
2025
Q4
$99.1M Buy
203,351
+158
+0.1% +$73.6K 0.02% 498
2025
Q3
$85.2M Sell
203,193
-81,875
-29% -$27.5M 0.02% 509
2025
Q2
$81.9M Buy
285,068
+27,406
+11% +$8.19M 0.02% 576
2025
Q1
$79.4M Buy
257,662
+25,289
+11% +$8.67M 0.02% 589
2024
Q4
$82M Buy
232,373
+19,716
+9% +$7.25M 0.02% 557
2024
Q3
$76.2M Sell
212,657
-31,298
-13% -$10.6M 0.02% 581
2024
Q2
$77.7M Buy
243,955
+79,333
+48% +$21M 0.02% 513
2024
Q1
$37.8M Buy
164,622
+1,207
+0.7% +$272K 0.01% 651
2023
Q4
$35.9M Buy
163,415
+9,999
+7% +$2.3M 0.01% 654
2023
Q3
$34.7M Buy
153,416
+49,440
+48% +$11.4M 0.02% 651
2023
Q2
$23.3M Hold
103,976
0.01% 737
2023
Q1
$23.3M Buy
103,976
+22,349
+27% +$5.51M 0.01% 737
2022
Q4
$22.7M Buy
81,627
+1,679
+2% +$424K 0.01% 722
2022
Q3
$16.7M Sell
79,948
-4,112
-5% -$919K 0.01% 808
2022
Q2
$19.8M Sell
84,060
-6,055
-7% -$1.23M 0.01% 742
2022
Q1
$16.2M Buy
90,115
+2,791
+3% +$532K 0.01% 906
2021
Q4
$18.9M Sell
87,324
-7,923
-8% -$1.56M 0.01% 911
2021
Q3
$17.6M Buy
95,247
+2,485
+3% +$489K 0.01% 903
2021
Q2
$16.6M Sell
92,762
-21,968
-19% -$4.18M 0.01% 940
2021
Q1
$19.2M Sell
114,730
-305
-0.3% -$50.9K 0.01% 874
2020
Q4
$17.5M Buy
115,035
+7,116
+7% +$934K 0.01% 882
2020
Q3
$10.9M Sell
107,919
-618
-0.6% -$67.8K 0.01% 922
2020
Q2
$13.1M Sell
108,537
-5,072
-4% -$571K 0.01% 848
2020
Q1
$10.8M Buy
113,609
+11,086
+11% +$1.05M 0.01% 843
2019
Q4
$9.03M Buy
102,523
+46,100
+82% +$4.06M 0.01% 976
2019
Q3
$4.5M Sell
56,423
-1,564
-3% -$126K ﹤0.01% 1247
2019
Q2
$4.53M Sell
57,987
-223,761
-79% -$20.9M ﹤0.01% 1237
2019
Q1
$33.1M Buy
281,748
+126,081
+81% +$14.7M 0.02% 609
2018
Q4
$17M Sell
155,667
-1,009
-0.6% -$117K 0.01% 737
2018
Q3
$20M Buy
156,676
+13,983
+10% +$1.73M 0.01% 754
2018
Q2
$16.1M Buy
142,693
+13,092
+10% +$1.44M 0.01% 819
2018
Q1
$14.6M Buy
129,601
+10,152
+8% +$1.29M 0.01% 830
2017
Q4
$17.7M Sell
119,449
-5,288
-4% -$672K 0.02% 781
2017
Q3
$14.6M Buy
124,737
+9,213
+8% +$1.18M 0.01% 816
2017
Q2
$15M Buy
115,524
+9,606
+9% +$1.2M 0.01% 816
2017
Q1
$14.3M Sell
105,918
-117,304
-53% -$17.8M 0.01% 811
2016
Q4
$32M Sell
223,222
-34,242
-13% -$4.37M 0.04% 514
2016
Q3
$30.4M Buy
257,464
+10,901
+4% +$1.31M 0.03% 527
2016
Q2
$26.1M Buy
246,563
+20,278
+9% +$2.26M 0.03% 563
2016
Q1
$25.2M Buy
226,285
+15,402
+7% +$1.95M 0.03% 565
2015
Q4
$33M Buy
210,883
+107,084
+103% +$15.6M 0.04% 486
2015
Q3
$13.6M Buy
103,799
+10,626
+11% +$1.7M 0.02% 792
2015
Q2
$16.2M Buy
93,173
+57,901
+164% +$10.4M 0.02% 778
2015
Q1
$6.08M Buy
35,272
+6,385
+22% +$973K 0.01% 1010
2014
Q4
$3.74M Sell
28,887
-24,147
-46% -$3.11M ﹤0.01% 1115
2014
Q3
$6.82M Buy
53,034
+3,840
+8% +$396K 0.01% 965
2014
Q2
$4.35M Sell
49,194
-17,694
-26% -$1.7M ﹤0.01% 1064
2014
Q1
$6.29M Buy
66,888
+29,070
+77% +$2.97M 0.01% 987
2013
Q4
$4.28M Buy
37,818
+1,650
+5% +$149K ﹤0.01% 1039
2013
Q3
$2.85M Sell
36,168
-1,559
-4% -$114K ﹤0.01% 1129
2013
Q2
$2.48M Buy
+37,727
New +$2.43M ﹤0.01% 1139

Other funds holding UTHR